Welcome + Community Resources
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
How do I craft this?
Discussion about Path of Exile, a free ARPG made by Grinding Gear Games
Marty Makary talks DOGE cuts, new voucher program and why FDA still 'on track' to meet all PDUFA dates
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Second patient death reported with gene therapy for muscular dystrophy
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Kennedy's ACIP to review the use of vaccines containing thimerosal and aluminum adjuvants
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Sage’s Story Comes to ‘Good End’ With Up To $795M Acquisition by Supurnus
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Pfizer pays 3SBio $1.25B for PD-1xVEGF bispecific, joining red-hot race with BioNTech, Merck
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Prime Medicine CEO exits as biotech shelves sole clinical gene therapy, lays off 25% of staff
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Regeneron to acquire 23andMe for $256 million
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
250 more NIH workers laid off, including cuts at the National Cancer Institute
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Medtech Exits: What Surmodics-FTC Block Means for Medtech Space
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
AACR: Boehringer Ingelheim proves durability of 'unparalleled' HER2-mutant lung cancer candidate
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Merck takes $200M tariff hit, trimming its gross profits
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Pharma-Biopharma field in Ireland…
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
New Website For Contracting and Consulting Jobs
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Harvard Built the Biotech Industry in Cambridge, Then Let It Go. Now It Wants Back In. | News | The Harvard Crimson
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Pharma employees can no longer serve on FDA advisory committees
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
VOLT pulsed field ablation approved in Europe
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Glycomine raises $115M to see if it can treat rare glycosylation disorder
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Abbott Laboratories enters the competitive intravascular lithotripsy (IVL) market with FDA approval for an IDE to evaluate its Coronary IVL System, challenging Boston Scientific and Johnson & Johnson
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
Trump says ‘major’ pharmaceutical tariffs on the way
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
As FDA slashes workforce, number of new medical devices reaching the public has fallen (Star Tribune gift link)
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
FDA Misses Review Deadline for Novavax’s COVID-19 Shot, Days After Marks’ Resignation
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma
A central location for Pharmaceutical, Biotech, Medical Device, and Diagnostics Industry-centered discussion.
